Exciting Developments at Axiom Brain Health
Axiom Brain Health and the Global Alzheimer’s Platform Foundation (GAP) have marked a significant milestone in neurodegenerative research. The recent launch of their newly renovated facility reflects a profound commitment to advancing research into conditions like Alzheimer’s, Multiple Sclerosis, and Parkinson’s disease. This event took place recently in a welcoming atmosphere brimming with hope and community support.
Welcoming New Opportunities
At the inauguration, the leaders of Axiom and GAP expressed their gratitude towards all guests. Among them was a local Citizen Scientist whose dedication to volunteer work at Axiom made real contributions towards clinical trials. The importance of such volunteerism was highlighted as an essential element in the quest for better treatment options.
The Role of Volunteers in Research
Richard Cacciatore, a Tampa local and long-time volunteer, shared his inspiring journey. His involvement in clinical trials comes from a deeply personal desire to make a difference in the fight against Alzheimer’s. "I’ve met incredible people and learned from numerous research studies," he shared. Cacciatore emphasized his hope that his efforts would contribute to slowing the progress of Alzheimer’s disease, or possibly even discovering a cure.
Facility Expansion for Future Research
The newly renovated facility has tripled in size, evolving from a single suite of 1,700 square feet to a spacious 3,900 square foot three-suite design. This expansion allows for an increased team of 14 specialized research professionals dedicated to uncovering therapies and potential cures for devastating neurodegenerative disorders.
Community Impact and Access to Research
Dr. Susan Steen, a key player in this transformation, expressed her excitement, stating, "It is an honor to unveil our newly renovated site and provide the community with cutting-edge clinical research opportunities. I am proud of our growing team at Axiom and grateful to all the cherished volunteers who make our work possible." The new facility aims to play a crucial role in making advanced research accessible to more members of the community.
A Vision for the Future
John Dwyer, President of GAP, echoed this sentiment, praising the Axiom team’s 20-plus years of service to Tampa. "It is heartening to see the transformation of this research center, as it will expand Tampa’s access to the best clinical research available," he noted. The hope is that the enhanced facility will meet the needs of a broader spectrum of seniors, eager to engage with the latest in brain health research.
About the Global Alzheimer’s Platform Foundation
Founded to accelerate the delivery of Alzheimer’s treatments, GAP is a nonprofit organization that prioritizes diversity in clinical trials. Its mission encompasses not only enhancing the efficiency of Alzheimer's Disease clinical research but also ensuring inclusivity in participation. Currently, GAP supports over 100 research sites globally, with a keen focus on enhancing the clinical trial process.
Frequently Asked Questions
What is the purpose of the newly renovated Axiom facility?
The renovated facility aims to enhance research efforts focused on neurodegenerative diseases, providing a space for advanced clinical trials and improved community access to studies.
How can volunteers contribute to neurodegenerative research?
Volunteers play a crucial role by participating in clinical trials, providing valuable data and support that help researchers understand and treat diseases like Alzheimer’s.
What types of research are conducted at Axiom Brain Health?
Axiom Brain Health conducts research primarily on Alzheimer’s, Multiple Sclerosis, Parkinson’s, and other neurodegenerative diseases, seeking effective therapies and cures.
Why is diversity important in clinical research?
Diversity in clinical research ensures that all demographics are accurately represented, leading to more applicable findings and better treatment options for everyone.
How long has Axiom Brain Health been operational?
Axiom Brain Health has been serving the Tampa community for over 20 years, contributing significantly to the field of neurodegenerative research and clinical trials.
